CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells.
Zhou S, Lin W, Jin X, Niu R, Yuan Z, Chai T, Zhang Q, Guo M, Kim SS, Liu M, Deng Y, Park JB, Choi SI, Shi B, Yin J.
Zhou S, et al. Among authors: yuan z.
Cell Rep Med. 2024 Nov 28:101844. doi: 10.1016/j.xcrm.2024.101844. Online ahead of print.
Cell Rep Med. 2024.
PMID: 39637858